Literature DB >> 25952950

Correlation of structure and function of the macula in patients with retinitis pigmentosa.

R Battu1, A Khanna1, B Hegde2, T T J M Berendschot3, S Grover4, J S A G Schouten3.   

Abstract

PURPOSE: To correlate the structure of the macula, as measured by spectral-domain optical coherence tomography (SD-OCT) and function, as measured by microperimetry (MAIA) in patients with retinitis pigmentosa (RP) and relatively good visual acuity.
DESIGN: Prospective, cross-sectional, non-intervention study.
SUBJECTS: Patients with RP.
METHODS: Thirty patients with RP and good central visual acuity were identified. Each patient underwent SD-OCT of the macula and microperimetry. The images were overlaid using the custom-designed software. The retinal sensitivity by microperimetry was correlated with corresponding retinal thickness, as measured by the SD-OCT. ELM, COST, and IS/OS junction were scored as intact, disrupted, or absent. MAIN OUTCOME MEASURES: Comparing the retinal sensitivity on the MAIA with various measurements on the SD-OCT.
RESULTS: The retinal sensitivity on the MAIA showed a significant correlation with total retinal thickness and outer retinal thickness on the SD-OCT. There was no association with either the inner retinal thickness or the choroidal thickness. ORT showed a statistically significant correlation with the anatomical classification of ELM (r=-0.76, P<0.001), IS/OS (r=-0.800, P<0.001), and COST (r=-0.733, P<0.001).
CONCLUSION: This study determined that there was a high correlation of the structure and function of the central macula in patients with RP. These studies are important to establish surrogate markers that can be used as end points for various tests in future therapeutic clinical trials.

Entities:  

Mesh:

Year:  2015        PMID: 25952950      PMCID: PMC4506342          DOI: 10.1038/eye.2015.61

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  31 in total

1.  The significance of external limiting membrane status for visual acuity in age-related macular degeneration.

Authors:  Akio Oishi; Masayuki Hata; Masataka Shimozono; Michiko Mandai; Akihiro Nishida; Yasuo Kurimoto
Journal:  Am J Ophthalmol       Date:  2010-07       Impact factor: 5.258

2.  Fourier-domain optical coherence tomography and microperimetry findings in retinitis pigmentosa.

Authors:  Stefano Lupo; Pier Luigi Grenga; Enzo Maria Vingolo
Journal:  Am J Ophthalmol       Date:  2010-11-20       Impact factor: 5.258

3.  Correlation between visual function and photoreceptor inner/outer segment junction in patients with retinitis pigmentosa.

Authors:  S Aizawa; Y Mitamura; T Baba; A Hagiwara; K Ogata; S Yamamoto
Journal:  Eye (Lond)       Date:  2008-01-11       Impact factor: 3.775

Review 4.  Use of fundus perimetry (microperimetry) to quantify macular sensitivity.

Authors:  Klaus Rohrschneider; Stefan Bültmann; Christina Springer
Journal:  Prog Retin Eye Res       Date:  2008-08-03       Impact factor: 21.198

5.  A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography.

Authors:  M Dominik Fischer; Johannes C Fleischhauer; Mark C Gillies; Florian K Sutter; Horst Helbig; Daniel Barthelmes
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-25       Impact factor: 4.799

6.  Relationship between peripheral visual field loss and vision-related quality of life in patients with retinitis pigmentosa.

Authors:  T Sugawara; A Hagiwara; A Hiramatsu; K Ogata; Y Mitamura; S Yamamoto
Journal:  Eye (Lond)       Date:  2009-07-10       Impact factor: 3.775

Review 7.  Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis.

Authors:  Gerald J Chader; James Weiland; Mark S Humayun
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

8.  Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors.

Authors:  Mei Hong Tan; Alexander J Smith; Basil Pawlyk; Xiaoyun Xu; Xiaoqing Liu; James B Bainbridge; Mark Basche; Jenny McIntosh; Hoai Viet Tran; Amit Nathwani; Tiansen Li; Robin R Ali
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

9.  Normal central retinal function and structure preserved in retinitis pigmentosa.

Authors:  Samuel G Jacobson; Alejandro J Roman; Tomas S Aleman; Alexander Sumaroka; Waldo Herrera; Elizabeth A M Windsor; Lori A Atkinson; Sharon B Schwartz; Janet D Steinberg; Artur V Cideciyan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

10.  Structure-function correlation of the human central retina.

Authors:  Peter Charbel Issa; Eric Troeger; Robert Finger; Frank G Holz; Robert Wilke; Hendrik P N Scholl
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

View more
  16 in total

1.  The association between cone density and visual function in the macula of patients with retinitis pigmentosa.

Authors:  Tomoko Ueda-Consolvo; Hironori Ozaki; Tomoko Nakamura; Toshihiko Oiwake; Atsushi Hayashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-06-06       Impact factor: 3.117

Review 2.  Dysflective Cones.

Authors:  Jacque L Duncan; Austin Roorda
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 3.650

Review 3.  Optical coherence tomography in the evaluation of retinitis pigmentosa.

Authors:  Jin Kyun Oh; Yan Nuzbrokh; Jose Ronaldo Lima de Carvalho; Joseph Ryu; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2020-06-19       Impact factor: 1.274

4.  Developing an Outcome Measure With High Luminance for Optogenetics Treatment of Severe Retinal Degenerations and for Gene Therapy of Cone Diseases.

Authors:  Artur V Cideciyan; Alejandro J Roman; Samuel G Jacobson; Boyuan Yan; Michele Pascolini; Jason Charng; Simone Pajaro; Sheila Nirenberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.799

5.  Assessing Visual Fields in Patients with Retinitis Pigmentosa Using a Novel Microperimeter with Eye Tracking: The MP-3.

Authors:  Nozomi Igarashi; Masato Matsuura; Yohei Hashimoto; Kazunori Hirasawa; Hiroshi Murata; Tatsuya Inoue; Obata Ryo; Makoto Aihara; Ryo Asaoka
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

6.  Assessment of Central Visual Function in Patients with Retinitis Pigmentosa.

Authors:  Kohta Fujiwara; Yasuhiro Ikeda; Yusuke Murakami; Takashi Tachibana; Jun Funatsu; Yoshito Koyanagi; Shunji Nakatake; Noriko Yoshida; Shintaro Nakao; Toshio Hisatomi; Shigeo Yoshida; Takeshi Yoshitomi; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

7.  Quantifying microstructural changes in retinitis pigmentosa using spectral domain - optical coherence tomography.

Authors:  B Poornachandra; Aruj K Khurana; Preethi Sridharan; Priyansha Chatterjee; Chaitra Jayadev; Naresh Kumar Yadav; Rohit Shetty
Journal:  Eye Vis (Lond)       Date:  2019-05-15

8.  Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome.

Authors:  Lynn W Sun; Ryan D Johnson; Christopher S Langlo; Robert F Cooper; Moataz M Razeen; Madia C Russillo; Alfredo Dubra; Thomas B Connor; Dennis P Han; Mark E Pennesi; Christine N Kay; David V Weinberg; Kimberly E Stepien; Joseph Carroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

9.  Structure-Function Modeling of Optical Coherence Tomography and Standard Automated Perimetry in the Retina of Patients with Autosomal Dominant Retinitis Pigmentosa.

Authors:  Travis B Smith; Maria Parker; Peter N Steinkamp; Richard G Weleber; Ning Smith; David J Wilson
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

10.  Edge of Scotoma Sensitivity as a Microperimetry Clinical Trial End Point in USH2A Retinopathy.

Authors:  Jason Charng; Tina M Lamey; Jennifer A Thompson; Terri L McLaren; Mary S Attia; Ian L McAllister; Ian J Constable; David A Mackey; John N De Roach; Fred K Chen
Journal:  Transl Vis Sci Technol       Date:  2020-09-09       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.